(294) pcDNA3.1-myc-OGA(1-400)
(Plasmid
#168095)
-
PurposeMyc tagged truncated human OGA catalytic domain of residues 1-400
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 168095 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1(+)
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5347
- Total vector size (bp) 6592
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namemyc-OGA(1-400)
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1245
- Promoter T7/CMV
-
Tag
/ Fusion Protein
- myc (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site Sgfl (not destroyed)
- 3′ cloning site XbaI (not destroyed)
- 5′ sequencing primer T7 fwd
- 3′ sequencing primer BGH rev (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
(294) pcDNA3.1-myc-OGA(1-400) was a gift from Christina Woo (Addgene plasmid # 168095 ; http://n2t.net/addgene:168095 ; RRID:Addgene_168095) -
For your References section:
Target protein deglycosylation in living cells by a nanobody-fused split O-GlcNAcase. Ge Y, Ramirez DH, Yang B, D'Souza AK, Aonbangkhen C, Wong S, Woo CM. Nat Chem Biol. 2021 Mar 8. pii: 10.1038/s41589-021-00757-y. doi: 10.1038/s41589-021-00757-y. 10.1038/s41589-021-00757-y PubMed 33686291